Researchers have developed a fast and inexpensive way to make facial prostheses for eye cancer patients using facial scanning software and 3-D printing, according to findings released today at AAO 2014, the 118th annual meeting ...
Oct 20, 2014
0
0
Researchers at the University of California, San Diego School of Medicine have identified a therapeutic target for treating the most common form of eye cancer in adults. They have also, in experiments with mice, been able ...
May 29, 2014
0
0
(HealthDay)—A drug used against a common virus may lengthen the lives of people with a deadly form of brain cancer, a preliminary study suggests.
Sep 5, 2013
0
0
A multistate study led by researchers at the University of Utah has revealed that the risk for childhood cancer is moderately increased among children and young adolescents with certain types of major birth defects. Children ...
Aug 12, 2013
0
0
(HealthDay)—You may never have heard of aniridia, a genetic disorder that robs people of their vision. But researchers studying the condition say it could give insight into some common health problems—from cataracts and ...
Aug 2, 2013
0
0
An anti-cancer drug has been proven to be equally as effective in treating the most common cause of blindness in older adults as a more expensive drug specifically formulated for this purpose.
Jul 19, 2013
0
0
A type of genetic abnormality linked to cancer is more common in people with type 2 diabetes than the rest of the population, a new study has found.
Jul 14, 2013
0
0
A new class of drug targeting skin cancer's genetic material has been successfully tested in humans for the first time, opening the way to new treatments for a range of conditions from skin cancers to eye diseases.
May 7, 2013
0
0
Adding omega-3 fatty acids did not improve a combination of nutritional supplements commonly recommended for treating age-related macular degeneration (AMD), a major cause of vision loss among older Americans, according to ...
May 6, 2013
0
0
German chemical and pharmaceutical company Bayer AG said Thursday that its net profit rose 11.5 percent in the first quarter as new drugs, led by blood thinner Xarelto, boosted sales.
Apr 25, 2013
0
0
